Exane Derivatives’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
Exane Derivatives's QGEN Position: Q2 2022 in Review
Exane Derivatives increased its Qiagen (QGEN) stake by 12% in Q2 2022, buying an estimated $80.7K and bringing the position to 15,692 shares worth $773K. The position accounts for 0.44% of the portfolio, ranked #54.
Exane Derivatives first reported a position in QGEN in Q1 2017 and has held it in 12 quarters since. The position peaked at $2.41M in Q1 2017. 287 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.
- Exane Derivatives held 15,692 shares of Qiagen worth $773K as of Q2 2022.
- Exane Derivatives bought 1,654 Qiagen shares in Q2 2022, an estimated $80.7K.
- Qiagen made up 0.44% of Exane Derivatives's portfolio in Q2 2022, its #54 holding.
- Exane Derivatives first reported a position in Qiagen in Q1 2017 and has held it in 12 quarters since.
- Exane Derivatives's Qiagen position peaked at $2.41M in Q1 2017.
- 287 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.